Ocean Biomedical, Inc. (OCEA) quarterly cash flow statement — complete operating, investing & financing history
| Cash from Operations | -356K | -2.52M | -885K | -290K | -485K | -866K | -1.13M | -4.78M | -2.65M | -143.8K | -313.79K | -152K |
| Operating CF Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating CF Growth % | 26.6% | -190.99% | 21.68% | 93.94% | 81.71% | -502.23% | -260.11% | -3046.05% | -622.34% | -1.27% | 47.61% | 22.05% |
| Net Income | -8.24M | 283K | -5.53M | -17.23M | 13M | -16.86M | -14.09M | -13.03M | -67.4M | 410.05K | -1.02M | -7.33M |
| Depreciation & Amortization | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Stock-Based Compensation | 186K | 186K | 186K | 373K | 186K | 187K | 186K | 186K | 646K | 0 | 2.93M | 4.9M |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | 6.94M | -1.43M | 4.22M | 15.8M | -14.23M | 17.02M | 11.19M | 9.49M | 62.18M | -1.02M | -351.77K | 115K |
| Working Capital Changes | 759K | -1.56M | 235K | 767K | 561K | -1.22M | 1.58M | -1.43M | 1.93M | 471.07K | 1.06M | 2.17M |
| Change in Receivables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | 854K | -671K | 238K | 536K | 766K | -805K | 1.54M | -1.26M | 1.45M | -1.92M | -142K | 79.59K |
| Cash from Investing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -1.05M | -1.05M | 0 |
| Capital Expenditures | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| CapEx % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash from Financing | 909K | 2.5M | 896K | 0 | 0 | 839K | 0 | 6.64M | 2.92M | 1.05M | 1.26M | 255K |
| Debt Issued (Net) | 909K | -896K | 896K | 0 | 0 | 740K | 0 | 5.19M | 875K | 1.31M | 1.05M | 165K |
| Equity Issued (Net) | 0 | 0 | 0 | 0 | 0 | -50.56M | -51.61M | 52.07M | 1.58M | 0 | 209.13K | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | -51.61M | 0 | -12.68M | 0 | 0 | 0 |
| Other Financing | 0 | 3.4M | 0 | 0 | 0 | 50.66M | 51.61M | -50.63M | 464K | -261K | 0 | 90K |
| Net Change in Cash | 553K | -16K | 11K | -290K | -485K | -27K | -1.13M | 1.85M | 272K | -143.8K | -104.65K | 103K |
| Free Cash Flow | -356K | -2.52M | -885K | -290K | -485K | -866K | -1.13M | -4.78M | -2.65M | -143.8K | -313.79K | -152K |
| FCF Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| FCF Growth % | 26.6% | -190.99% | 21.68% | 93.94% | 81.71% | -502.23% | -260.11% | -3046.05% | -622.34% | -1.27% | 47.61% | 22.05% |
| FCF per Share | -0.01 | -0.09 | -0.03 | -0.01 | -0.02 | -0.03 | -0.04 | -0.18 | -0.11 | -0.01 | -0.02 | -0.01 |
| FCF Conversion (FCF/Net Income) | 0.04x | -8.90x | 0.16x | 0.02x | -0.04x | 0.05x | 0.08x | 0.37x | 0.02x | -0.35x | 0.31x | 0.02x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |